Spur Therapeutics
Founded 2015 · 278 employees on LinkedIn · 3 known investors
Spur Therapeutics develops gene therapies aiming to halt the progression of chronic conditions with a single dose of genetic medicine. Its pipeline includes a gene therapy candidate for Gaucher disease and programs targeting more widespread conditions such as forms of Parkinson's, dementia, and certain cardiovascular diseases.
Investors · 3
Frequently asked questions
- What does Spur Therapeutics do?
- Spur Therapeutics develops gene therapies aiming to halt the progression of chronic conditions with a single dose of genetic medicine. Its pipeline includes a gene therapy candidate for Gaucher disease and programs targeting more widespread conditions such as forms of Parkinson's, dementia, and certain cardiovascular diseases.
- Who are Spur Therapeutics's investors?
- Spur Therapeutics's investors include AlbionVC, Syncona, UCL Technology Fund.